Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 5 pathways; mostly iron and oxidative stress | 0.80 |
No case: the score is under the bar. Receipt 13065
Sealed predictions
- GGT5 in dopamine neurons, braak-0.58 (p 0.102) → -0.43 (p 0.243)receipt 13072
Swarm cases
receipt 13072: GGT5 in dopamine neurons, braak
- power
- full sample -0.56 (p 0.016, n 18), 95% CI -0.81 to -0.13. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.54 (p 0.019, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.61 (p 0.0075, n 18). not the mix.
- skeptic
- leave-one-out range -0.67 to -0.50, sign flips 0; without severely affected donors -0.56 (p 0.016, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GGT5 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts